
Secured Loan Note Update and Notice of AGM
Posted on: Wednesday, August 05, 2009Meldex announces that it has, today, written to all Qualifying Shareholders with an update on and revisions to the Secured Loan Note (“SLN”) issue.
As announced by the Company on 24 July, the Directors intend to propose a resolution to Members at the Annual General Meeting to increase the ordinary share capital by an amount sufficient to allow the conversion of any convertible loan note offered in substitution for the SLN into ordinary shares at a conversion price of 2p per share.
Under the original terms of the SLN Offer, if subscriptions totalling in aggregate £6,000,000 have not been received by close of business on the extended closing date (11 August), then all funds held in escrow (including interest payable on these monies) will be returned to each SLN Applicant.
The Directors are now seeking the consent of each SLN Applicant to allow the Company to retain their subscription monies notwithstanding that the Minimum Subscription may not be achieved. Full details of why this consent is being sought, and the conditions under which this would or would not occur, are set out in the documentation which has been sent to Qualifying Shareholders.
A “Consent Form” has been sent to all Qualifying Shareholders as part of the updated SLN documentation.
Any SLN Applicant who has subscribed for Loan Notes or who subscribes for Loan Notes before 5.00pm on 11 August 2009 must ensure that a completed Consent Form has been received by Mills & Reeve LLP by 5.00pm on 11 August 2009 otherwise all funds held in escrow by Mills & Reeve LLP on behalf of SLN Applicants will be returned, and their application will be cancelled.
Meldex further announces that the Company’s Annual General Meeting will be held at Abington Hall Conference Centre, Granta Park, Great Abington, Cambridge CB21 6GP, United Kingdom on Friday 28 August at 10.00am.
The Company has, today, sent a full copy of the Notice of Annual General Meeting to all Shareholders on the Shareholder Register.
Other current news items
Distribution Agreement for Menoflavon® in JordanPosted on: Tuesday, May 25, 2010
Kudos™ Licensing Agreement
Posted on: Friday, May 14, 2010
Distribution Agreement for Menoflavon® in Singapore
Posted on: Thursday, April 15, 2010
Meldex International PLC 2008 Financial Statements
Posted on: Thursday, January 07, 2010
Announcement: Execution of Memorandum of Understanding
Posted on: Tuesday, December 08, 2009
Distribution Agreement for Menoflavon® in the Netherlands
Posted on: Tuesday, November 03, 2009
Restoration of Registrar Services
Posted on: Thursday, October 15, 2009
Company Update
Posted on: Tuesday, October 13, 2009
Distribution Agreement for Menoflavon® in Canada
Posted on: Friday, October 02, 2009
Company Update
Posted on: Friday, September 25, 2009
Distribution Agreement for Menoflavon® in Austria
Posted on: Friday, September 18, 2009
Update on the Secured Loan Note Offer
Posted on: Wednesday, September 02, 2009
Result of Annual General Meeting
Posted on: Friday, August 28, 2009
Distribution Agreement for Menoflavon® and Melprotect® in United Arab Emirates
Posted on: Monday, August 24, 2009
Secured Loan Note update
Posted on: Friday, July 24, 2009
Extension to Secured Loan Note offer deadline
Posted on: Wednesday, July 22, 2009
Appointment of Consultant Project Manager
Posted on: Thursday, July 16, 2009
Distribution Agreement for Menoflavon® in Germany
Posted on: Friday, July 10, 2009
Appointment of Consultant Project Manager
Posted on: Friday, July 10, 2009
Proceedings issued against former Directors
Posted on: Saturday, July 04, 2009
Collaboration Agreement for Meltums™ Pharma Development
Posted on: Thursday, July 02, 2009
Secured Loan Note Applications
Posted on: Wednesday, July 01, 2009
Menoflavon® Distribution Agreements
Posted on: Monday, June 29, 2009
Launch of Secured Loan Note Offer
Posted on: Thursday, June 25, 2009
Distribution Agreement for Menoflavon® in Belgium
Posted on: Wednesday, June 24, 2009
Company Update
Posted on: Monday, June 15, 2009
Product Availability Matrix
Posted on: Thursday, June 11, 2009
Cancellation of Share Options
Posted on: Wednesday, June 03, 2009
Oradisc™ Benzocaine now at Regulatory stage
Posted on: Tuesday, May 05, 2009
Hintz Joint Venture announcement
Posted on: Thursday, April 09, 2009

